Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OculoMotor Technologies has developed a virtual reality-based platform for diagnosing and treating visual disorders using real-time eye tracking. Their solutions are research-backed, with evidence supporting efficacy in both clinical practice and ongoing trials for conditions such as concussion-related convergence insufficiency. The company has received significant grant funding to further develop its technology.[2][6]\n\nNo published pivotal trial results yet; products are available for use by clinicians.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OculoMotor Technologies.